The effectiveness of intravenous 5-fluorouracil-containing chemotherapy after curative resection for gastric carcinoma: A systematic review of published randomized controlled trials

Journal of Chemotherapy

Volumn 19, Issue 4, 2007, Pages 359-374

  Hu, Jian Kun ^a   Li, Chun Mei ^b   Chen, Xin Zu ^a   Chen, Zhi Xin ^a   Zhou, Zong Guang ^a   Zhang, Bo ^a   Chen, Jia Ping ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

5 fluorouracil; Gastric carcinoma; Surgery for gastric carcinoma

Indexed keywords

CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; MITOMYCIN C; SEMUSTINE; UFT; VINBLASTINE; VINCRISTINE;

ANEMIA; ANOREXIA; BRAIN TOXICITY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; ESOPHAGITIS; GASTRECTOMY; HEALTH CARE COST; HUMAN; LEUKOPENIA; LUNG TOXICITY; META ANALYSIS; MORTALITY; MUCOSA INFLAMMATION; NAUSEA; NEPHROTOXICITY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SKIN TOXICITY; STOMACH CARCINOMA; STOMATITIS; SURVIVAL RATE; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; VOMITING;

EID: 34547747401     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2007.19.4.359     Document Type: Review

References (61)

1. Chen XM, Chen GY, Wang ZR et al. Detection of micrometastasis of gastric carcinoma in peripheral blood circulation. World J Gastroenterol 2004; 10(6):804-808.
2. Shimada K, Ajani JA. Adjuvant therapy for gastric carcinoma patients in the past 15 years. Cancer 1999; 86(9):1657-1668.
3. Yu W. Impact of perioperative intraperitoneal chemotherapy on the treatment of primary gastric cancer. Surg Oncol Clin N Am. 2003;12(3):623-634, xi.
4. Wei G, Fang GE, Bi JW et al. Efficacy of intraoperative hypotonic peritoneal chemo-hyperthermia combined with early postoperative intraperitoneal chemotherapy on gastric cancer. Ai Zheng. 2005;24(4):478-482. Chinese
5. Ajani J. Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers. Cancer. 2006;107(2):221-231.
6. Arima S, Ohsato K, Hisatsugu T, Shimura H. Multicentre randomised study of adjuvant chemotherapy with mitomycin C and tegafur or tegafur-uracil in gastric cancer. Eur J Surg. 1994;160(4):227-232.
7. Macdonald JS, Fleming TR, Peterson RF et al. Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study. Ann Surg Oncol. 1995;2(6):488-494.
8. Higuchi K, Phan A, Ajani JA. Gastric cancer: advances in adjuvant and adjunct therapy. Curr Treat Options Oncol. 2003;4(5):413-419.
9. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: gastric cancer - v.1.2006. www.nccn.org/professionals/physician_gls/ PDF/gastric.pdf.
10. Bouche O, Ychou M, Burtin P et al. Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann Oncol. 2005;16(9):1488-1497.
11. Nitti D, Wils J, Dos Santos JG et al. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Ann Oncol. 2006;17(2):262-269.
12. Jeung HC, Rha SY, Noh SH et al. Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute. Cancer. 2001;91(11):2016-2025.
13. Hu JK, Chen ZX, Zhou ZG et al. Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials. World J Gastroenterol 2002; 8(6):1023-1028.
14. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 1996;17(1):1-12.
15. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd.
16. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17(24):2815-2834.
17. Bajetta E, Buzzoni R, Mariani L et al. Adjuvant chemotherapy in gastric cancer: 5-year results of randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Ann Oncol 2002;13(2):299-307.
18. The Italian Gastrointestinal Tumor Study Group: Adjuvant treatments following curative resection for gastric cancer. Br J Surg 1988;75(11):1100- 1104.
19. Chen W, Li RL, Sui GJ. Adjuvant chemotherapy can improve the late result of radical operation in patients with gastric cancer. Zhongliu Fangzhi Yanjiu 1994;21(3):163-165. Chinese.
20. Chipponi J, Huguier M, Pezet D et al. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. Am J Surg 2004;187(3):440-445.
21. Coombes RC, Schein PS, Chivers CED et al. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. J Clin Oncol 1990;8(8):1362-1369.
22. The Gastrointestinal Tumor Study Group. Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. Cancer 1982;49(6):1116-1122.
23. Engstrom PF, Lavin FT, Douglass HO, Brunner AKW. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Cancer 1985;55(9):1868-1873.
24. Higgins GA, Amadeo JH, Smith DE, Humphrey EW, Keehn RJ. Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A Veterans Administration Surgical Oncology, Group report. Cancer. 1983 Sep 15;52(6):1105-1112.
25. Huguier M, Destroyes JP, Baschet C, Le Henand F, Bernard PF. Gastric carcinoma treated by chemotherapy after resection: a controlled study. Am J Surg 1980;139(2):197-199.
26. Kim JP, Kwon OH, Oh ST, Yang HK. Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann Surg 1992; 216(3):269-279.
27. Krook JE, O'Connell MJ, Wieand HS et al. A prospective, randomized evaluation of intensive-course 5-Fluorouracil plus Doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer. Cancer 1991;67(10):2454-2458.
28. Li U, Wang LY, Cai L et al. Combined treatment of surgery with chemotherapy of stomach cancer: an analysis 5-year following up of 649 patients. Shiyong Zhongliuxue Zazhi 1994;8(3):57-58,79. Chinese.
29. Nakajima T, Takahashi T, Takagi K, Kuno K, Kajitani T. Comparison of 5-Fluorouracil with Ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer. J Clin Oncol 1984;2(12):1366-1371.
30. Nakajima T, Nashimoto A, Kitamura M et al. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group. Lancet 1999;354(9175):273-277.
31. Nashimoto A, Nakajima T, Furukawa H et al. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. J Clin Oncol 2003;21(12):2282-2287.
32. Neri B, Cini G, Andreoli F et al. Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up. Br J Cancer 2001;84(7): 878-880.
33. Popiela T, Kulig J, Czupryna A, Szczepanik AM, Zembala M. Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer. Gastric Cancer 2004;7(4):240-245.
34. Schlag P. Adjuvant chemotherapy in gastric cancer. World J Surg 1987;11(4):473-477.
35. Tsavaris N, Tentas K, Kosmidis P et al. A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer. Chemotherapy. 1996;42(3):220-226.
36. Wang BD, Zhang GY, Leng GZ. The effect of chemotherapy in respectable gastric cancer. Dangdai Zhongliuxue Zazhi 1994;1(2):137-138. Chinese.
37. Fielding JW, Fagg SL, Jones BG et al. An interim report of a prospective, randomized, controlled study of adjuvant An interim report of a prospective, randomized, controlled study of adjuvant. World J Surg. 1983;7(3):390-399.
38. Yamamura Y, Yasue M, Kito T, Nakazato H, Yamada E. Adjuvant immunochemotherapy combined with OK-432 following surgery of stomach cancer. Gan To Kagaku Ryoho. 1983;10(7):1603-1609. Japanese.
39. Imaizumi M, Kondo T, Kamei H, Ichihashi H. Cooperative studies on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer. Gan To Kagaku Ryoho. 1984;11(1):60-68. Japanese.
40. Jakesz R, Dittrich C, Funovics J et al. Adjuvant chemotherapy in patients with radical resection of stomach cancer: 5-year results of a prospective randomized study. Wien Klin Wochenschr. 1986;98(24):824-830. German.
41. Yamamura Y, Nishimura M, Sakamoto J et al. A randomized controlled trial of surgical adjuvant therapy with mitomycin C, 5-fluorouracil and OK-432 in patients with gastric cancer. Gan To Kagaku Ryoho. 1986;13(6):2134-2140. Japanese.
42. Jakesz R, Dittrich C, Funovics J et al. The effect of adjuvant chemotherapy in gastric carcinoma is dependent on tumor histology: 5-year results of a prospective randomized trial. Recent Results Cancer Res. 1988;110:44-51.
43. Allum WH, Hallissey MT, Kelly KA. Adjuvant chemotherapy in operable gastric cancer. 5 year follow-up of first British Stomach Cancer Group trial. Lancet. 1989;1(8638):571-574.
44. Allum WH, Hallissey MT, Ward LC, Hockey MS. A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group. Br J Cancer. 1989;60(5):739-744.
45. Imaizumi M, Kondo T, Kamei H, Ichihashi H. Cooperative study on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer (II). Cooperative study group on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer supported by the Ministry of Health and Welfare (Kondo's group). Gan To Kagaku Ryoho. 1990;17(12):2397-2403. Japanese.
46. Lise M, Nitti D, Marchet A et al. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer. J Clin Oncol. 1995;13(11):2757-2763.
47. Lise M, Nitti D, Marchet A et al. Prognostic factors in resectable gastric cancer: results of EORTC study no. 40813 on FAM adjuvant chemotherapy. Ann Surg Oncol. 1995;2(6):495-501.
48. Imada T, Sairenji M, Suda T, Yamamoto Y, Amano T, Motohashi H. A combination chemotherapy of 5-fluorouracil and cisplatin against advanced gastric cancer. Hepatogastroenterology. 1999;46(25):594-600.
49. Bresciani C, Gama-Rodrigues J, Strassmann V, Waitzberg DL, Matsuda M, Pinotti HW. Long term (five-year) survival following radical surgical treatment plus adjuvant chemotherapy (FAM) in advanced gastric cancer: a controlled study. Rev Hosp Clin Fac Med Sao Paulo. 2000;55(4):129-136.
50. Nakajima T. Evaluation of adjuvant UFT for gastric cancer. Oncology (Williston Park). 2000;14(10 Suppl 9):82-86.
51. Kim JP, Yu HJ, Lee JH. Results of immunochemosurgery for gastric carcinoma. Hepatogastroenterology. 2001;48(41):1227-1230.
52. Hundahl SA, Macdonald JS, Benedetti J, Fitzsimmons T; Southwest Oncology Group and the Gastric Intergroup. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol. 2002;9(3):278-286.
53. Hermans J, Bonenkamp JJ, Boon MC et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.J Clin Oncol 1993;11(8):1441-1447.
54. Mari E, Floriani I, Tinazzi A et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 2000;11(7):837-843.
55. Katai H, Sano T, Sasako M, Fukagawa T, Saka M. Update on surgery of gastric cancer: new procedures versus standard technique. Dig Dis. 2004;22(4):338-344.
56. Fiorica F, Cartei F, Venturi A et al. Impact of combined external radiotherapy on survival in gastric cancer: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2005;63(Suppl 1):S280-S281.
57. Kitamura M, Arai K, Iwasaki Y. Evaluation of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer. Gan To Kagaku Ryoho 1997;24(10):1221-1229. Japanese
58. Janunger KG, Hafstrom L, Nygren P, Glimelius B. A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol 2001;40(2-3):309-326.
59. Panzini I, Gianni L, Fattori PP et al. Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori 2002;88(1):21-27.
60. Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 1999;35(7):1059-1064.
61. Nakajima T, Ota K, Ishihara S, Oyama S, Nishi M, Hamashima N. Meta-analysis of 10 postoperative adjuvant chemotherapies for gastric cancer in CIH. Gan To Kagaku Ryoho 1994;21(11):1800-1805. Japanese